Literature DB >> 30910867

Clinical Characteristics and Prognostic Factors of Patients with Intrahepatic Cholangiocarcinoma with Fever: A Propensity Score Matching Analysis.

Zi-Jun Gong1,2, Jian-Wen Cheng1, Pin-Ting Gao1, Ao Huang1, Yun-Fan Sun1, Kai-Qian Zhou1, Bo Hu1, Shuang-Jian Qiu1, Jian Zhou1,3, Jia Fan1,3, Xin-Rong Yang4.   

Abstract

BACKGROUND: Patients with intrahepatic cholangiocarcinoma (ICC) rarely present fever as the initial symptom. We aimed to identify clinical characteristics and prognostic factors for these feverish patients. SUBJECTS, MATERIALS, AND METHODS: This study retrospectively reviewed 31 patients with ICC with fever (≥38.0°C) treated at our hospital between January 2002 and December 2014. A propensity score was used to match patients with and without fever at a ratio of 1:2.
RESULTS: Patients with ICC with fever had higher serum γ-glutamyl transferase and carcinoembryonic antigen levels, larger tumors, poorer tumor differentiation, and worse prognosis (all p < .05) than those without fever. This was supported by propensity score matching (PSM) analysis. Univariate and multivariate analyses indicated that microvascular invasion, hilar lymph node metastasis, and temperature ≥ 38.6°C were related to prognosis. Patients with ICC with fever had higher levels of leucocytes, neutrophils, neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) in peripheral blood before and after PSM analysis. Body temperature positively correlated with leucocytes (r = 0.599, p < .001), neutrophils (r = 0.644, p < .001), NLR (r = 0.681, p < .001), and PLR (r = 0.457, p = .010).
CONCLUSION: Patients with ICC with fever ≥38.0°C and ≥38.6°C had poor and extremely poor prognosis, respectively. Radical surgical treatment may improve the prognosis of patients with ICC with fever <38.6°C. However, systemic therapy (e.g., anti-inflammatory and immune therapy) may be preferable to surgery for these patients with fever ≥38.6°C. IMPLICATIONS FOR PRACTICE: Patients with intrahepatic cholangiocarcinoma (ICC) with fever (≥38.0°C) as the initial symptom are extremely rare. Because their symptoms are similar to those of liver abscess, diagnosis is challenging, and most of these patients are already at an advanced stage at the time of diagnosis. Patients with ICC with fever had different clinical characteristics and worse prognosis than those without fever. The prognosis of those with temperature <38.6°C would be improved by timely surgical intervention. Those with fever ≥38.6°C had an extremely dismal outcome, although they all received radical surgical treatment. New therapeutic strategies are needed to improve survival for patients with ICC with temperature ≥38.6°C. © AlphaMed Press 2019.

Entities:  

Keywords:  Fever; Hepatectomy; Intrahepatic cholangiocarcinoma; Prognosis

Mesh:

Substances:

Year:  2019        PMID: 30910867      PMCID: PMC6656462          DOI: 10.1634/theoncologist.2018-0268

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  39 in total

1.  Primary liver cancer presenting as pyogenic liver abscess: characteristics, diagnosis, and management.

Authors:  Cong Li; Guangbing Li; Ruoyu Miao; Xin Lu; Shouxian Zhong; Xinting Sang; Yilei Mao; Haitao Zhao
Journal:  J Surg Oncol       Date:  2011-09-22       Impact factor: 3.454

Review 2.  New insights into molecular diagnostic pathology of primary liver cancer: Advances and challenges.

Authors:  Wen-Ming Cong; Meng-Chao Wu
Journal:  Cancer Lett       Date:  2015-08-11       Impact factor: 8.679

3.  Malignant causes of fever of unknown origin.

Authors:  Vanessa Foggo; Jamie Cavenagh
Journal:  Clin Med (Lond)       Date:  2015-06       Impact factor: 2.659

Review 4.  Differences in immunohistochemical biomarkers between intra- and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis.

Authors:  Jimme K Wiggers; Anthony T Ruys; Bas Groot Koerkamp; Ulrich Beuers; Fiebo J ten Kate; Thomas M van Gulik
Journal:  J Gastroenterol Hepatol       Date:  2014-08       Impact factor: 4.029

5.  Interleukin-1β/Iinterleukin-1 receptor-associated kinase 1 inflammatory signaling contributes to persistent Gankyrin activation during hepatocarcinogenesis.

Authors:  Bo Su; Tao Luo; Junjie Zhu; Jing Fu; Xiaofang Zhao; Lei Chen; Huilu Zhang; Yibin Ren; Lexing Yu; Xiaojun Yang; Mengchao Wu; Gensheng Feng; Shao Li; Yao Chen; Hongyang Wang
Journal:  Hepatology       Date:  2015-01-05       Impact factor: 17.425

Review 6.  Emerging molecular therapeutic targets for cholangiocarcinoma.

Authors:  Sumera Rizvi; Gregory J Gores
Journal:  J Hepatol       Date:  2017-04-05       Impact factor: 25.083

7.  Proliferative activity in hepatocellular carcinoma is closely correlated with glucose metabolism but not angiogenesis.

Authors:  Koji Kitamura; Etsuro Hatano; Tatsuya Higashi; Masato Narita; Satoru Seo; Yuji Nakamoto; Kenya Yamanaka; Hiromitsu Nagata; Kojiro Taura; Kentaro Yasuchika; Takashi Nitta; Shinji Uemoto
Journal:  J Hepatol       Date:  2011-02-18       Impact factor: 25.083

8.  Prognostic Nomogram Based on Histological Characteristics of Fibrotic Tumor Stroma in Patients Who Underwent Curative Resection for Intrahepatic Cholangiocarcinoma.

Authors:  Chu-Yu Jing; Yi-Peng Fu; Jin-Long Huang; Mei-Xia Zhang; Yong Yi; Wei Gan; Xin Xu; Hu-Jia Shen; Jia-Jia Lin; Su-Su Zheng; Juan Zhang; Jian Zhou; Jia Fan; Zheng-Gang Ren; Shuang-Jian Qiu; Bo-Heng Zhang
Journal:  Oncologist       Date:  2018-09-26

9.  Serum interleukin-6 levels correlate with prognosis in diffuse large-cell lymphoma.

Authors:  J F Seymour; M Talpaz; F Cabanillas; M Wetzler; R Kurzrock
Journal:  J Clin Oncol       Date:  1995-03       Impact factor: 44.544

Review 10.  Intermediate filament cytoskeleton of the liver in health and disease.

Authors:  P Strnad; C Stumptner; K Zatloukal; H Denk
Journal:  Histochem Cell Biol       Date:  2008-04-29       Impact factor: 4.304

View more
  3 in total

1.  Decreased size of the left anterior descending coronary artery is an independent predictor of deterioration in non-high-risk patients with acute pulmonary embolism.

Authors:  Dong Jia; Yizhuo Gao
Journal:  J Thromb Thrombolysis       Date:  2021-01       Impact factor: 2.300

2.  Multiparametric Magnetic Resonance Imaging Improves the Prognostic Outcomes in Patients With Intrahepatic Cholangiocarcinoma After Curative-Intent Resection.

Authors:  Qian Li; Yi Wei; Feng Che; Tong Zhang; Shan Yao; Jian Zhao; YuHui Zhang; Hehan Tang; Bin Song
Journal:  Front Oncol       Date:  2022-03-09       Impact factor: 6.244

3.  A Study on Mesoporous Silica Loaded With Novel Photosensitizers HCE6 and Oxaliplatin for the Treatment of Cholangiocarcinoma.

Authors:  Pei-Jian Zhang; Meng-Dong Liu; Fang-Yong Fan; Ke-Xia Liu
Journal:  Front Oncol       Date:  2021-06-29       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.